Testing treatments affecting uterine bleeding during periods
Part of Women’s health & pregnancy clinical trials.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 45 and have regular periods
- You are not pregnant within 3 months before joining the study
- You are not breastfeeding (lactating) when you enroll
- You are not using hormonal birth control or a copper IUD
- You are not taking medicines that affect clot breakdown (antifibrinolytics) or blood thinners (anticoagulants)
- You can complete the study’s bleeding diary (PBAC) and you can avoid sex for 2 weeks before the uterine lining biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at an outpatient procedure that removes part of the uterine lining to reduce very heavy menstrual bleeding. It may help you if birth control or medicines haven’t worked (or you can’t take them) and your uterus tests come back normal.
This study tests whether different types of hormonal medication (such as pills or an intrauterine device) can help manage heavy periods in adolescents and young adults. The goal is to find what works best for reducing bleeding and improving quality of life.
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
This study follows people with adenomyosis to see which treatments work best for pain and heavy bleeding. It may help doctors find better ways to manage symptoms.
This study tests a minimally invasive surgical procedure to treat heavy menstrual bleeding caused by thickened uterine muscle tissue. The goal is to reduce bleeding and improve quality of life in women who haven't benefited from medication alone.
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Hear when a new Menstrual Bleeding, Heavy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.